Evidence Hub

Neonatal Giant Hepatic Hemangioma: A Case Report

F. Mbarki, Ilyas lamsalla, K. Skalli, D. Oukachou, Fouzia Hmami

Scholars Journal of Medical Case Reports, 2025

2 citations

Abstract

nfantile hepatic hemangiomas (IH) represent a rare but important group of benign liver tumors in children. Although often asymptomatic, large or symptomatic hemangiomas can cause severe complications requiring timely therapeutic intervention. Diagnosis relies on advanced imaging modalities such as Doppler ultrasound, CT, and MRI. We report the case of a newborn with a prenatally detected abdominal mass initially suspected to be a cystic lymphangioma. Following treatment with propranolol, a significant reduction in the mass size was observed, leading to the diagnosis of a rapidly involuting congenital hepatic hemangioma (RICH). This case illustrates the efficacy of propranolol in the management of symptomatic hepatic hemangiomas in neonates.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free